Neogenomics Inc
NEO- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- SEC CIK
- 0001077183
In the last 90 days, Neogenomics Inc insiders filed 0 open-market purchases and 1 sale; 266 institutions reported holding it in 13F filings for Q2 2026, worth $2.11B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Neogenomics Inc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 274
- +21 vs. Q1 2025
- Shares held
- 127.1M
- +1.94M (+1.5%) vs. Q1 2025
- Total value
- $930.2M
- −$259.8M (−21.8%) vs. Q1 2025
- New holders
- 59
- 97 more added
- Sold out
- 38
- 67 more reduced
3 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NEO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 266 | $2.11B |
| Q1 2026 | 253 | $995.3M |
| Q4 2025 | 257 | $1.54B |
| Q3 2025 | 254 | $995.4M |
| Q2 2025 | 274 | $930.2M |
| Q1 2025 | 256 | $1.20B |
| Q4 2024 | 253 | $2.02B |
| Q3 2024 | 270 | $1.82B |
| Q2 2024 | 259 | $1.74B |
| Q1 2024 | 263 | $2.02B |
| Q4 2023 | 287 | $2.04B |
| Q3 2023 | 284 | $1.48B |
| Q2 2023 | 267 | $1.89B |
| Q1 2023 | 257 | $2.02B |
| Q4 2022 | 244 | $1.04B |
| Q3 2022 | 246 | $969.0M |
| Q2 2022 | 240 | $956.4M |
| Q1 2022 | 281 | $1.36B |
| Q4 2021 | 309 | $4.02B |
| Q3 2021 | 325 | $5.58B |
| Q2 2021 | 313 | $5.03B |
| Q1 2021 | 332 | $5.21B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Neogenomics Inc; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bellevue Asset Management, LLC | 0 | $0 | 0.00% | −112−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Bogart Wealth, LLC | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −58−100.0% | Sold out |
| Bare Financial Services, Inc | 0 | $0 | 0.00% | −48−100.0% | Sold out |
| Private Wealth Management Group, LLC | 0 | $0 | 0.00% | −41−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Hexagon Capital Partners LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| DiNuzzo Private Wealth, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Bay Harbor Wealth Management, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −37−100.0% | Sold out |
| Hemington Wealth Management | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Glenmede Trust Co NA | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |
| Sofos Investments, Inc. | – | – | – | – | Not filed |